E-mail

E-mail a Wiley Online Library Link

Parkinson Study Group Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD) Movement Disorders 28

Article first published online: 30 SEP 2013 | DOI: 10.1002/mds.25639

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH